NCT07046520 is a NA clinical trial of High intensity interval training in Hematologic Test, sponsored by High Institute of Sports and Physical Education of Kef.

Who is sponsoring NCT07046520?

NCT07046520 is sponsored by High Institute of Sports and Physical Education of Kef.

What drugs are being tested in NCT07046520?

Interventions in NCT07046520: High intensity interval training.

What condition does NCT07046520 study?

NCT07046520 studies Hematologic Test.

Is NCT07046520 still recruiting?

NCT07046520 is currently completed. Last updated 4 July 2025.

Last reviewed 2025-07-04 · How we verify

NCT07046520

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of HIIT on Plasma Volume and Aerobic Capacity in Obese Adolescent Girls

Completed NA Last updated 4 July 2025

What this trial tests

NA trial testing High intensity interval training in Hematologic Test in 28 participants. Completed in 28 February 2025.

Timeline

9 December 2024

Primary endpoint
28 February 2025

28 February 2025

Quick facts

Lead sponsor	High Institute of Sports and Physical Education of Kef
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	28
Start date	9 December 2024
Primary completion	28 February 2025
Estimated completion	28 February 2025
Sites	1 location across Tunisia

Drugs / interventions tested

High intensity interval training

Conditions studied

Hematologic Test — all drugs for Hematologic Test →

Sponsor

High Institute of Sports and Physical Education of Kef

Who can join

Adults 15 to 17, female only, with Hematologic Test. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to investigate the impact of high-intensity interval training (HIIT) program on body composition, hematological parameters, plasma volume variations (PVV), muscle damage markers, and aerobic capacity in overweight/obese adolescent girls. The main question it aims to answer is: Does HIIT reduce risk factors associated obesity diseases by modulating body composition and hematological parameters and increasing PVV? Researchers will compare HIIT (designed to the experimental group) to nontraining intervention (designed to the control group) to see if the training program works to enhance physiological health and reduce risk factors associated with obesity in this population. Participants in the experimental (HIIT group) group will: underwent HIIT at 90-105% maximal aerobic speed (MAS), three times a week. Participants in control group will : not perform any physical training and maintain their usual daily activities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of High intensity interval training

Trials testing the same drug.

NCT07153523 — Effect of High Intensity Interval Training on Strength, Endurance and Flexibility · NA · recruiting
NCT07328568 — Effect of Low Volume Sprint Interval Training on Cardiorespiratory Fitness · NA · active not recruiting
NCT07025694 — Exercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study · NA · recruiting
NCT06509464 — Response Of Metabolic Syndrome Severity Score To High Intenisty Interval Training In Women With Central Obesity. · NA · recruiting
NCT07289373 — Moderate Versus High-intensity Interval Training in Children With Diplegia. · NA · completed

Other High Institute of Sports and Physical Education of Kef trials

Trials by the same sponsor.

NCT07264348 — Cardiometabolic and Hormonal Adaptations to 4-Month Zumba Training in Overweight/Obese Women · NA · not yet recruiting
NCT07103889 — Effect of Acute Exercise on Biochemical Parameters in Normal-Weight and Overweight/Obese Adolescent. · NA · completed
NCT07311460 — HIIT, Steroid Hormones and Mental Health in Adolescents · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07046520 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by High Institute of Sports and Physical Education of Kef
Last refreshed: 4 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07046520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing